Panupattanapong Sirada, Brooks Elizabeth B
Center for Pediatric Rheumatology and Immunology, Cleveland Clinic Children's
Center for Pediatric Rheumatology and Immunology, Cleveland Clinic Children's.
Cleve Clin J Med. 2020 Dec 31. doi: 10.3949/ccjm.87a.ccc039.
In April 2020, data began emerging on Kawasaki-like syndrome and hyperinflammatory response in children with COVID-19. Since then, much has been published on the presentation of COVID-19 in pediatric patients, including its association with Kawasaki disease and the multisystem inflammatory syndrome in children (MIS-C). However, questions still remain regarding the risk factors, pathogenesis, prognosis, and specific therapy for these manifestations of COVID-19.
2020年4月，有关新冠病毒疾病（COVID-19）患儿出现川崎样综合征和高炎症反应的数据开始出现。从那时起，已经发表了许多关于儿科患者COVID-19表现的文章，包括其与川崎病和儿童多系统炎症综合征（MIS-C）的关联。然而，关于COVID-19这些表现的危险因素、发病机制、预后和特异性治疗仍存在问题。
